Table 1.
Treatment | Day of treatment or re-infestation | ||||||
---|---|---|---|---|---|---|---|
0 | 7 | 14 | 21 | 28 | 35 | ||
Placebo | Range | 23 to 43 | 12 to 34 | 26 to 43 | 13 to 40 | 21 to 39 | 20 to 43 |
AM | 33.8 | 23.5 | 35.8 | 28.4 | 32.4 | 35.4 | |
GMc | 32.4a | 21.7a | 34.5a | 26.4a | 31.2a | 33.7a | |
Sarolaner | Range | 0 to 31 | 6 to 21 | 8 to 22 | 12 to 27 | 13 to 30 | 12 to 33 |
AM | 8.3 | 13.1 | 12.5 | 19.9 | 22.1 | 21.1 | |
AM Efficacy (%) | 75.6 | 44.1 | 65.0 | 30.0 | 31.7 | 40.3 | |
GMc | 3.4b | 12.1b | 11.6b | 18.6a | 20.6a | 19.8b | |
GM Efficacy (%) | 89.6 | 44.1 | 66.4 | 29.6 | 33.9 | 41.2 | |
P-value vs. placebo | <0.0001 | 0.0157 | <0.0001 | 0.1349 | 0.0766 | 0.0239 | |
Imidacloprid+permethrin | Range | 6 to 45 | 0 to 33 | 2 to 18 | 0 to 18 | 5 to 20 | 7 to 42 |
AM | 31.9 | 9.9 | 8.9 | 6.9 | 14.3 | 19.5 | |
AM Efficacy (%) | 5.6 | 58.0 | 75.2 | 75.8 | 56.0 | 44.9 | |
GMc | 27.6a | 4.2c | 7.2b | 4.7b | 12.8b | 16.8b | |
GM Efficacy (%) | 14.6 | 80.6 | 79.0 | 82.0 | 58.9 | 50.2 | |
P-value vs. placebo | 0.6216 | <0.0001 | <0.0001 | <0.0001 | 0.0074 | 0.0331 | |
P-value vs. sarolaner | <0.0001 | 0.0077 | 0.2152 | 0.0005 | 0.1917 | 0.6461 |
c Geometric means within columns with the same superscript are not significantly different (P >0.05)